Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SPYRAL AFFIRM Global Clinical Study of Renal Denervation With the Symplicity Spyral Renal Denervation System in Subjects With Uncontrolled Hypertension (SPYRAL AFFIRM)

NCT05198674 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

NCT NCT05198674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05198674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SPYRAL AFFIRM Global Clinical Study of Renal Denervation With the Symplicity Spyral Renal Denervation System in Subjects With Uncontrolled Hypertension (SPYRAL AFFIRM)
Lead sponsor
Medtronic Vascular
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 20, 2021
Completion date
November 30, 2029
Enrollment
1,899 (actual)
Sites
97

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic kidney diseases, diabetes mellitus, hypertension, vascular diseases